Acob, Abdilla C.
HRN: 27-08-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/20/2025
05/27/2025
IV
750
OD
CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes